2014-02-06T09:28:03-06:00 2013-06-30 KPMG LLP 345 PARK AVENUE NEW YORK NY 101540102 990 2012-07-01 231907729 JDRF INTERNATIONAL % JDRF INTERNATIONAL JDRF 2124797551 26 BROADWAY 15TH FLOOR Suite NEW YORK NY 10004 EDWARD SEBALD 2124797551 2014-02-06 true 2127589700 2012 2015-11-30 17:44:51Z JEFFREY BREWER 26 BROADWAY 14TH FLOOR NEW YORK NY 10004 266635962 false X www.jdrf.org X 1970 PA JDRF'S MISSION IS TO FIND A CURE FOR TYPE I DIABETES AND ITS COMPLICATIONS THROUGH THE SUPPORT OF RESEARCH. SEE SCHEDULE O 34 32 940 300000 40676 29449 195105087 196010663 650 0 6976700 9200541 985636 1012287 203068073 206223491 110071078 106005315 0 0 63750813 68158134 339000 339000 23702529 31190949 34993292 205351840 209495741 -2283767 -3272250 187007468 196040120 150608537 162509815 36398931 33530305 X SEE SCHEDULE O false false 106005315 106005315 JDRF PROVIDES RESEARCH FUNDING. See schedule O 17451616 JDRF CONDUCTS SYMPOSIA AND LECTURES. SEE SCHEDULE O. 46349723 JDRF EDUCATES THE PUBLIC ABOUT DIABETES AND ITS COMPLICATIONS. SEE SCHEDULE O. 169806654 true true false true false false false false false true true true false false true false true false false true true true false true true true false true false true false false false false false false true false true false false false true true false false false true X 294 6 true 940 true true true true IS NL DA false false false true true false false false true false X 34 32 false false false false false false false true true false true true true true true true true true true true true true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X JDRF INTERNATIONAL 2124797551 26 BROADWAY 14TH FLOOR NEW YORK NY 10004 CYNTHIA FORD FY11-13 3.0 X FRANCIS J INGRASSIAFY-11-13 3.0 X JAMES F MCDONALD FY11-13 3.0 X PATRICK MCFEELEY FY11-13 3.0 X GLEN E TULLMAN FY11-13 3.0 X DICK ALLEN FY11-13 20.0 X X MARY ELIZABETH BUNZELFY12-14 3.0 X X MIKE HENDREN FY11-13 3.0 X STEVE HITCHINS FY12-14 3.0 X DAVID W NELMS FY12-14 3.0 X X DIANE ADAMS FY13-15 3.0 X SHANNON ALLEN FY13-15 3.0 X DAVID REHR FY13-15 3.0 X RIK KIRKLAND FY11-13 3.0 X ELLEN LEAKE FY12-14 3.0 X KAREN CASE FY11-13 3.0 X TOM CHAPMAN FY11-13 3.0 X MATTHEW COHN FY11-13 3.0 X DEREK RAPP FY11-13 3.0 X REBECCA DAVIES FY11-13 3.0 X MAARTEN DE GROOT FY12-14 3.0 X RED MAXWELL FY12-14 3.0 X CAROL OXENREITER FY11-13 3.0 X LORRAINE STIEHL FY12-14 3.0 X LORNE SHIFF FY12-14 3.0 X MARK FISCHER-COLBRIE FY13-15 3.0 X NICOLE JOHNSON FY13-15 3.0 X MIKE LEE FY13-15 3.0 X PREETISH NIJHAWAN FY13-15 3.0 X BILL PARSONS FY13-15 3.0 X PAM SAGAN FY13-14 3.0 X LARRY SOLER FY13-15 3.0 X WENDY WOOD FY13-15 3.0 X PAM EDMONDS FY13-15 3.0 X EDWARD J SEBALD 50.0 X 232834 0 38458 JEFFREY BREWER 50.0 X GERRI BOSTICK 50.0 X 246278 0 20338 JAMES SZMAK 50.0 X 284000 0 38458 DR RICHARD A INSEL 50.0 X 536450 0 38458 DARLENE DEECHER 50.0 X 300000 0 38458 JULIA GREENSTEIN 50.0 X 252938 0 20354 MIKE MALEKOFF 50.0 X 222431 0 34335 SCOTT MCCORMICK 50.0 X 225000 0 1346 2299931 0 230205 118 false true false LW ROBBINS 201 SUMMER STREET HOLLISTON MA 01746 FUNDRAISING CONSULT 2577600 HELLER CONSULTING 1736 FRANKLIN STREET OAKLAND CA 94612 FUNDRAISING SYSTEMS 1420366 HICKORY PRINTING SOLUTIONSLLC PO Box 69 HICKORY NC 28603 PRINTING CONSULTANT 780006 LEK CONSULTING 1133 6TH AVE NEW YORK NY 10036 MANAGEMENT CONSULT 768370 MTM TECHNOLOGIES 1200 HIGH RIDGE ROAD STAMFORD CT 06905 IT CONSULTANT 521792 27 4406173 122740842 68863648 13616269 196010663 0 2055756 40676 2015080 0 0 0 0 0 40709392 33564607 7144785 7144785 7144785 26711064 122740842 26711064 0 1074451 136800 937651 937651 0 MISCELLANEOUS REVENUE 900099 74636 74636 74636 206223491 40676 10172152 77609371 77609371 0 28395944 28395944 0 970930 601977 150494 218459 110987 68812 17203 24972 52599532 32611708 8152928 11834896 1421388 881261 220315 319812 8915737 5527757 1381939 2006041 4139560 2566527 641632 931401 2283179 1919547 317797 45835 474057 350802 47406 75849 235967 174615 23597 37755 973471 720369 97347 155755 339000 339000 654512 474339 75451 104722 32336 23928 3234 5174 3147439 1598899 299007 1249533 2211655 1123521 210107 878027 2976710 1762212 553668 660830 0 9690260 5736634 1802388 2151238 3058628 1988108 428208 642312 0 2241585 1457030 313822 470733 0 0 3195000 1891440 594270 709290 412634 244279 76750 91605 OUTREACH EXPENSES 1356822 827661 230660 298501 DUES & SUBSCRIPTIONS 1599823 975892 271970 351961 BAD DEBT WRITE OFF & RES EXP 328181 200190 55791 72200 OTHER MISC EXPENSES 121033 73831 20574 26628 209495741 169806654 15986558 23702529 X 3042000 1093000 181000 1768000 6895502 2520529 6851236 11478825 16217279 20964333 11224003 13762501 0 0 0 0 0 0 0 0 2927347 3444264 29594385 9714001 12895011 19880384 55375921 67706583 72214207 53814254 2406962 2468447 0 0 0 0 187007468 196040120 12589033 13856286 129390933 139614273 6117990 6579425 0 0 0 0 0 0 0 0 0 0 2510581 2459831 150608537 162509815 X 4797995 -850019 24872971 27580079 6727965 6800245 36398931 33530305 187007468 196040120 -3272250 403624 X false true X true false X 179109955 192947945 198202755 195105087 196010663 961376405 0 0 179109955 192947945 198202755 195105087 196010663 961376405 0 961376405 3692824 3001134 3183733 2070575 2055756 14004022 0 0 0 35418 29449 64867 513903 172582 295028 117723 74636 1173872 976619166 0.98439 0.98114 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false 1000000 1000000 1000000 3000000 4500000 434852 300158 162802 897812 250000 250000 250000 750000 1125000 32712 92270 17263 142245 true true false true 104056 false 208505 true 6000 true 583567 true 83882 false 986010 false JDRF LOBBYING ACTIVITIES FORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with T1D, the goal of JDRF is to create a world without T1D. Through research and advocacy, JDRF is accelerating progress on the most promising opportunities to cure, treat, and prevent T1D. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance the discovery, development, and delivery of better therapies for T1D. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation. 6898880 100000 81000 171000 6908880 5806880 1227000 350000 485000 6898880 5413880 526000 133000 5806880 5207251 1098629 892000 5413880 5155646 51605 5207251 0.95000 0.05000 false false 4495000 1032639 3462361 25099385 8681362 16418023 19880384 HEDGE FUNDS & OTHER EQUITIES 53814254 F 53814254 0 SPLIT INTEREST CHRT RMDR TRUST 2459831 2459831 X 205972000 403624 403624 205568376 654512 603 655115 206223491 208841000 208841000 654512 229 654741 209495741 ADJUSTMENT DUE TO ROUNDING PART XI, LINE 4b ADJUSTMENT DUE TO ROUNDING, $603 ADJUSTMENT DUE TO ROUNDING PART XII, LINE 4B ADJUSTMENT DUE TO ROUNDING, $229 ORGANIZATION'S ENDOWMENT FUNDS FORM 990, PART X, LINE 13 & SCH D, PART V, LINE 4 THE INTENDED USE OF THE ORGANIZATION'S ENDOWMENT FUNDS IS TO USE THE FUNDS FOR BOTH SPECIFIC PROJECTS AS WELL AS SUPPORTING THE ORGANIZATION'S GENERAL EXEMPT PURPOSE INCOME TAX POSITIONS OF JDRF INT. 990 SCH-D, PART X, LINE 2 JDRF is a not for profit organization exempt from federal income taxes under Section 501(c)(3) of the Internal Revenue Code and is organized under the laws of the Commonwealth of Pennsylvania. The effect of income tax positions is recognized only if those positions are more likely than not of being sustained. Income generated from activities unrelated to JDRF's exempt purpose is subject to tax under Internal Revenue Code Section 511. Unrelated Business Income Tax liability was insignificant for the years ending June 30, 2013 and 2012. true North America Grantmaking RESEARCH GRANTS 5605450 East Asia and the Pacific Grantmaking RESEARCH GRANTS 5047121 Middle East and North Africa Grantmaking RESEARCH GRANTS 2154725 Europe (Including Iceland and Greenland) Grantmaking RESEARCH GRANTS 15588648 Central America and the Caribbean Investments 24324405 Europe (Including Iceland and Greenland) 1 1 Program Services RESEARCH ADMIN. 238790 1 1 1 1 52959139 52959139 East Asia and the Pacific 295687 CHECK/WIRE N/A N/A North America 109840 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 319716 CHECL/WIRE N/A N/A Europe (Including Iceland and Greenland) 342535 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 458357 CHECK/WIRE N/A N/A Middle East and North Africa 340940 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 1603998 CHECK/WIRE N/A N/A East Asia and the Pacific 366964 CHECK/WIRE N/A N/A East Asia and the Pacific 654882 CHECK/WIRE N/A N/A North America 165000 CHECK/WIRE N/A N/A Middle East and North Africa 46866 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 623936 CHECK/WIRE N/A N/A Middle East and North Africa 165000 CHECK/WIRE N/A N/A North America 712135 CHECK/WIRE N/A N/A North America 110000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 728694 CHECK/WIRE N/A N/A East Asia and the Pacific 435614 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 799996 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 379248 CHECK/WIRE N/A N/A North America 1653363 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 315000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 921984 CHECK/WIRE N/A N/A East Asia and the Pacific 254381 CHECK/WIRE N/A N/A North America 208532 CHECK/WIRE N/A N/A North America 94496 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 250000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 115000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 473897 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 400918 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 613018 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 444844 CHECK/WIRE N/A N/A East Asia and the Pacific 84139 CHECK/WIRE N/A N/A East Asia and the Pacific 235665 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 149943 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 193730 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 75000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 163000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 225615 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 294119 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 558442 CHECK/WIRE N/A N/A North America 145924 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 164904 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 309980 CHECK/WIRE N/A N/A North America 715951 CHECK/WIRE N/A N/A East Asia and the Pacific 1373583 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 497171 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 281921 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 487360 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 645000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 427143 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 249500 CHECK/WIRE N/A N/A Middle East and North Africa 1000000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 900000 CHECK/WIRE N/A N/A East Asia and the Pacific 44764 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 198000 CHECK/WIRE N/A N/A North America 250000 CHECK/WIRE N/A N/A North America 1165742 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 108530 CHECK/WIRE N/A N/A North America 109468 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 344708 CHECK/WIRE N/A N/A East Asia and the Pacific 53333 CHECK/WIRE N/A N/A East Asia and the Pacific 70000 CHECK/WIRE N/A N/A East Asia and the Pacific 97732 CHECK/WIRE N/A N/A East Asia and the Pacific 79603 CHECK/WIRE N/A N/A East Asia and the Pacific 30000 CHECK/WIRE N/A N/A East Asia and the Pacific 166420 CHECK/WIRE N/A N/A East Asia and the Pacific 612964 CHECK/WIRE N/A N/A East Asia and the Pacific 191390 CHECK/WIRE N/A N/A North America 165000 CHECK/WIRE N/A N/A Middle East and North Africa 437030 CHECK/WIRE N/A N/A Middle East and North Africa 164889 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 165000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 110000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 165000 CHECK/WIRE N/A N/A Europe (Including Iceland and Greenland) 70883 CHECK/WIRE N/A N/A 59 16 true false true true false false GRANT MONITORING PROCEDURES SCH-F PART I LINE 2 Research grants are awarded by the recommendations of a professional scientific staff at JDRF based on input from outside scientific reviewers and patient advocates. The following areas are evaluated: (1) The scientific merit of the application. (2) The relationship of the research to the causes, prevention and cure of diabetes and its complications. Also considered are the merits of the institutions and/or sponsors of the applicant, and the applicant's commitment to the continuing diabetes research programs. JDRF staff scrutinize expenditures reported by an institution above a percentage threshold of the approved budget. X X X X X true LW ROBBINS MAIL PROCESSOR MAIL PROCESSOR false 3999000 339000 3660000 CAR PROGRAM LLC 3755 OMEC CIRCLE 4 RANCHP CORDOVA CA 95742 CAR DONATION true 336159 162381 173778 4335159 501381 3833778 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY ILL WALK 4237882 203703 4034179 44525 34841 53745 10298 89141 ILL GALA 3246229 90704 3155525 44355 223662 241216 6733 432 141967795 122446435 19521360 1488629 3449138 2604424 3306998 15113359 149451906 122740842 26711064 1533154 3528334 2881831 3558512 15209233 26711064 1074451 85000 51800 1074451 85000 51800 136800 937651 AL AZ AR CA CO CT DE DC FL GA ID IN IA KS KY LA ME MH MA MI MN MS MO MT NE NV NJ NM NY NC OH OK OR PA RI SC SD TN TX UT VT VA WA WI true false false false 1.00000 GARY CURTO 26 BROADWAY-14TH FLOOR NEW YORK NY 10004 false GARY CURTO TAX MANAGER -JDRF ASSIST IN FILING GAMING APPLICATIONS, AND REPORTS. X true 937651 true BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON 1201 9TH AVE SEATTLE WA 98101 910653422 501(C)3 1362106 N/A N/A BLACK HILLS REGIONAL EYE INSTITUTE 2800 3RD ST RAPID CITY SD 57701 060646973 501(C)3 5357 N/A N/A BRIGHAM AND WOMENS HOSPITAL INC 77 AVE- LOUIS PASTEUR BOSTON MA 02115 042312909 501(C)3 439959 N/A N/A CASE WESTERN RESERVE UNIVERSITY 10900 EUCLID AVE CLEVELAND OH 44106 341018992 501(C)3 203775 N/A N/A CHILDRENS HOSPITAL BOSTON 300 LONGWOOD AVE BOSTON MA 02115 042774441 501(C)3 459169 N/A N/A BROWN UNIVERSITY PO BOX 1920 PROVIDENCE RI 02912 050258809 501(C)3 593141 N/A N/A EASTERN VIRGINIA MEDICAL SCHOOL 358 MOWBRAY ACH NORFOLK VA 23501 237053028 501(C)3 399546 N/A N/A HENRY FORD HEALTH SYSTEM 7800 W OUTER DR DETROIT MI 48202 580566256 501(C)3 170000 N/A N/A ALBERT EINSTEIN COLLEGE OF MEDICINE 1300 MORRIS PARK AVE BRONX NY 10461 237025620 501(C)3 251191 N/A N/A AUSTIN RETINA ASSOCIATES 801 WEST 38TH STREET AUSTIN TX 78705 999999999 20038 N/A N/A HARVARD MEDICAL SCHOOL 200 LONGWOOD AVE BOSTON MA 02115 042103580 501(C)3 3110127 N/A N/A CALIFORNIA INST OF TECHNOLOGY 383 S Hill AVE PASADENA CA 91125 999999999 501(C)3 35000 N/A N/A INDIANA UNIVERSITY 620 UNION DR INDIANAPOLIS IN 46202 356018940 501(C)3 472298 N/A N/A BETH ISRAEL MEDICAL CENTER 1 BROOKLINE AVE BOSTON MA 92121 135564934 501(C)3 55000 N/A N/A JOSLIN DIABETES CENTER 1 JOSLIN PL BOSTON MA 02215 042203836 501(C)3 2983015 N/A N/A LA JOLLA INSTITUTE FOR ALLERGY & IMMUNOLOGY 4660 LA JOLLA SAN DIEGO CA 92037 330328688 501(C)3 54460 N/A N/A CLOSE CONCERNS INC 804 HAIGHT STREET SAN FRANCISCO CA 94103 271518433 501(C)3 62000 N/A N/A MASSACHUSETTS INSTITUTE OF TECHNOLOGY 25 AMES ST CAMBRIDGE MA 02467 042103594 501(C)3 796225 N/A N/A INNOCENTIVE 201 JONES ROAD WALTHAN MA 02451 452019860 21000 N/A N/A UNIVERSITY OF NEBRASKA MEDICAL CENTER 42ND EMILE OMAHA NE 68198 470049123 501(C)3 107216 N/A N/A CALIFORNIA INST FOR BIOMEDICAL RESEARCH 11119 NTORRY PINES RD LAJOLLA CA 92037 956047739 501(C)3 867371 N/A N/A EMORY UNIVERSITY 69 JESSE HILL JR DRIVE ATLANTA GA 30322 580566256 501(C)3 483786 N/A N/A RETINA VITREOUS ASSOCIATES 610 SIERRA ROSE DR RENO NV 89144 999999999 38417 N/A N/A GEORGIA HEALTH SCIENCES UNIVERSITY 1120 15th Street ATLANTA GA 30394 586002053 501(C)3 201770 N/A N/A GEORGIA TECH RESEARCH CORP 505 TENTH STREET ATLANTA GA 30332 580603146 501(C)3 150000 N/A N/A MEDTRONIC 18000 DEVONSHIRE ST NORTHRIDGE CA 91325 411306950 6100000 N/A N/A STANFORD UNIVERSITY 300 PASTEUR DR PALA ALTO CA 94305 941156365 501(C)3 1578896 N/A N/A NATIONAL INST OF DIABETES & DIGESTIVE & KIDNEY DIS 9000 ROCKVILLE PIKE BETHESDA MD 20892 999999999 80784 N/A N/A CENTER FOR RETINA MACULA DISEASE 250 AVE K WINTER HAVEN FL 33880 593028408 11759 N/A N/A NATIONAL JEWISH HEALTH 601 EAST 18TH STREET DENVER CO 80206 742044647 501(C)3 260000 N/A N/A OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PORTLAND OR 97239 237083114 501(C)3 506586 N/A N/A THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 10010 N TORREY PINES RD LAJOLLA CA 92037 952160097 501(C)3 400000 N/A N/A THE SCHEPENS EYE RESEARCH INSTITUTE INC 20 STANIFORD ST BOSTON MA 02114 042129889 501(C)3 110000 N/A N/A THE SCRIPPS RESEARCH INSTITUTE 10550 N TORREY PINES RD LA JOLLA CA 92037 330435954 501(C)3 98190 N/A N/A THE BECKMAN RESEARCH INST OF THE CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953432210 501(C)3 284776 N/A N/A UNIVERSITY OF KANSAS CENTER FOR RESEARCH INC 1250 WESCOE HALL DR LAWRENCE KS 66045 421143702 501(C)3 5700 N/A N/A THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 609 MARY ELLEN CHAPEL HILL NC 27599 440680117 501(C)3 193831 N/A N/A OHIO STATE UNIVERSITY 281 WEST LANE AVE COLUMBUS OH 43210 316025986 501(C)3 219304 N/A N/A UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER 920 MADISON AVE MEMPHIS TN 38163 626001636 501(C)3 165000 N/A N/A UNIV OF TEXAS HEALTH SCI CENTER 7703 FLOYDE CURL DR SAN ANTONIO TX 78229 741761309 501(C)3 211864 N/A N/A UNIVERSITY OF TEXAS AT AUSTIN PO Box 8180 AUSTIN TX 78712 756002868 501(C)3 292500 N/A N/A UNIV OF COLORADO AT DENVER HEALTH SCI CENTER PO BOX 6511 DENVER CO 80045 846049811 501(C)3 1601726 N/A N/A UNIVERSITY OF FLORIDA 1600 SW ARCHER ROAD GAINESVILLE FL 32610 590974739 501(C)3 4299511 N/A N/A UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION INC 555 SOUTH FLOYD STREET LOUISVILLE KY 40202 611014882 501(C)3 765000 N/A N/A UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL 55 LAKE AVE NORTH WORCESTER MA 01605 043167352 501(C)3 400000 N/A N/A UNIVERSITY OF MIAMI SCHOOL OF MEDICINE 1450 NW 10TH AVE MIAMI FL 33136 590624458 501(C)3 1749424 N/A N/A UNIVERSITY OF VIRGINIA 104 MIDMONT LN CHARLOTTESVILLE VA 22902 416042488 501(C)3 1297144 N/A N/A UNIV OF MICHIGAN 1331 EAST ANN STREET ANN ARBOR MI 48109 386006309 501(C)3 1042863 N/A N/A UNIVERSITY OF PITTSBURGH E 1140 STARZL PITTSBURGH PA 15261 113708851 501(C)3 486251 N/A N/A UNIVERSITY OF CALIFORNIA AT SAN FRANCISCO 3333 CA ST SAN FRANCISCO CA 94122 956006143 501(C)3 5995570 N/A N/A UNIVERSITY OF SOUTH FLORIDA 3650 SPECTRUM BLVD TAMPA FL 33612 593102112 501(C)3 1215936 N/A N/A UNIVERSITY OF UTAH 201 PRESIDENTS CIR SALT LAKE CITY UT 84112 237112869 501(C)3 107795 N/A N/A UNIVERSITY OF WISCONSIN-MADISON 21 NORTH PARK MADISON WI 53706 396006492 501(C)3 601834 N/A N/A UT SOUTHWESTERN MEDICAL CENTER 5323 HARRY HINES BLVD DALLAS TX 75390 756002868 501(C)3 250331 N/A N/A VANDERBILT UNIVERSITY MEDICAL CENTER 1211 MEDICAL CENTER DR NASHVILLE TN 37232 620476822 501(C)3 814120 N/A N/A WASHINGTON UNIVERSITY IN ST LOUIS 4559 SCOTT AVE ST LOUIS MO 63110 430653611 501(C)3 450000 N/A N/A WILMER EYE INSTITUTE 600 N WOLFE STREET BALTIMORE MD 21287 520595110 501(C)3 96460 N/A N/A YALE UNIVERSITY 149 ELM STREET NEW HAVEN CT 06520 060646973 501(C)3 1933200 N/A N/A BAYLOR COLLEGE OF MEDICINE-RESEARCH INSTITUTE 3500 GASTON AVE DALLAS TX 75246 751921898 501(C)3 54578 N/A N/A BECTON DICKINSON MEDICAL 1 BECTON DR FRANKLIN LAKES NJ 07417 220760120 5550000 N/A N/A THE BROAD INSTITUTE OF HARVARD & MIT 7 CAMBRIDGE CENTER CAMBRIDGE MA 02142 263428781 501(C)3 1131700 N/A N/A DUKE UNIVERSITY 4321 MEDICAL PARK DR DURHAM NC 27704 560532129 501(C)3 368243 N/A N/A MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK RD MILWAUKEE WI 53226 390806261 501(C)3 150000 N/A N/A MILLER SCHOOL OF MEDICINE 1450 NW 10TH AVE MIAMI FL 33136 650244316 501(C)3 632356 N/A N/A FLORIDA RETINA INST 1025 PRIMERA LAKE MARY FL 32746 592009089 14637 N/A N/A SANSUM DIABETES RESEARCH 2219 BATH ST SANTA BARBARA CA 93105 951684086 501(C)3 323844 N/A N/A JAEB CENTER FOR HEALTH RESEARCH FND 15310 Amberly Drive Suite 350 TAMPA FL 33647 593187624 501(C)3 2583534 N/A N/A VIACYTE 3550 GENERAL ATOMICS SAN DIEGO CA 92121 999999999 4000000 N/A N/A TUFTS MEDICAL CENTER 4 COLBY STREET MEDFORD MA 02111 043400617 501(C)3 110000 N/A N/A LEK CONSULTING 28 STATE STREET BOSTON MA 02109 043313799 768370 N/A N/A AMYLIN PHARMACEUTICALS 9360 Towne Centre Drive SAN DIEGO CA 92121 753019302 646198 N/A N/A UNIVERSITY OF ARIZONA 811 N Euclid Ave Tucson AZ 85724 113661893 501(C)3 223697 N/A N/A LIGHT WHITE INNOVATION TECHNOLOGY 2391 HICKMAN ROAD ANN ARBOR MI 48105 999999999 35000 N/A N/A NEW YORK UNIVERSITY MEDICAL SCHOOL 550 1ST AVE NEW YORK NY 10016 111630830 501(C)3 953949 N/A N/A RETINA GROUP OF FLORIDA 5601 N DIXIE HWY FORT LAUDERDALE FL 33334 650017482 6192 N/A N/A RETINA MACULA INSTITUTE 4201 TORRANCE TORRANCE CA 90503 200804641 12701 N/A N/A RETINA INSTITUTE OF HAWAII 1620 ALA MOANA BLVD HONOLULU HI 96815 990300258 8437 N/A N/A SOUTHEAST RETINA CENTER 3685 WHEELER ROAD AUGUSTA GA 30909 581594221 21902 N/A N/A TEXAS RETINA ASSOCIATES 9600 NORTH CENTRAL EXPRESSWAY SUIT DALLAS TX 75231 751362336 9688 N/A N/A UNIVERSITY OF ALABAMA COLLEGE DRIVE BIRMINGHAM AL 35294 636001138 501(C)3 299330 N/A N/A MASSACHUSETTS GENERAL HOSPITAL 55 FRIUT STREET BOSTON MA 02114 042697983 501(C)3 821786 N/A N/A NORTHWESTERN UNIVERSITY 633 CLARK STREET EVANSTON IL 60208 231352685 501(C)3 1024197 N/A N/A DANA-FARBER CANCER INSTITUTE 450 BROOKLINE AVE BOSTON MA 02115 042263040 501(C)3 376504 N/A N/A RENSSELAER POLYTECHNIC INSTITUTE 110 EIGHTH AVE TROY NY 12180 141340095 501(C)3 49732 N/A N/A SELECTRA BIOSCIENCE INC 480 ARSENAL STREET WATERTOWN MA 02472 999999999 25000 N/A N/A WINTHROP INSTITUTE HOSPITAL 95 MINEOLA BLV MINEOLA NY 11501 111633486 501(C)3 149998 N/A N/A SPOKANE EYE CLINIC 427 S BERNARD ST SPOKANE WA 99204 452887234 9385 N/A N/A ST JUDE CHILDREN'S RESEARCH HOSPITAL 262 DANNY THOMAS PLACE MEMPHIS TN 38105 620646012 501(C)3 90000 N/A N/A TANDEM DIABETES CARE INC 11065 ROSELLE SAN DIEGO CA 92121 204327508 650000 N/A N/A UNIVERSITY OF CENTRAL FLORIDA 4000 CENTRAL BLVD ORLANDO FL 32816 596211832 501(C)3 155142 N/A N/A UNIVERSITY OF CHICAGO 5801 SOUTH ELLIS AVE CHICAGO IL 60637 362177139 501(C)3 310099 N/A N/A MOUNT SINAI SCHOOL OF MEDICINE 1 GUSTAVE L LEVY PLACE NEW YORK NY 10029 136171197 501(C)3 690320 N/A N/A RETINA RESEARCH CENTER 3705 MEDICAL PARKWAY AUSTIN TX 78705 711023026 17460 N/A N/A RETINAL CONSULTANTS OF ARIZONA 1101 MISSOURI AVE PHOENIX AZ 85014 860708606 10003 N/A N/A THE JACKSON LABORATORY 600 MAIN STREET BAR HARBOR ME 04609 999999999 216520 N/A N/A STATE UNIVERSITY OF NY AT BUFFALO 12 CAPEN HALL BUFFALO NY 14260 141368361 501(C)3 239310 N/A N/A GENERAL HOSPITAL CORP 55 FRUIT STREET BOSTON MA 02114 042697983 501(C)3 251966 N/A N/A GENOMICS INSTITUTE-NOVARTIS RES FND 10675 JOHN HOPKINS DR SAN DIEGO CA 92121 223610512 2890282 N/A N/A ILLINOIS INSTITUTE OF TECHNOLOGY 3300 SOUTH FEDERAL STREET CHICAGO IL 60616 362170136 501(C)3 292735 N/A N/A SANFORD RESEARCH 2301 E 60TH ST NORTH SIOUX FALLS SD 57104 460450378 315000 N/A N/A T1D EXCHANGE 11 AVE DE LAFAYETTE BOSTON MA 02111 451623549 2035065 N/A N/A UNIVERSITY OF MARYLAND 22 S GREENE ST COLLEGE PARK MD 20742 526002033 501(C)3 17500 N/A N/A UNIVERSITY OF MINNESOTA 80 SOUTH 8TH STREET MINNEAPOLIS MN 55455 416007513 501(C)3 150000 N/A N/A 77 26 GRANT MONITORING PROCEDURES SCH-I PART I LINE 2 Research grants are awarded by the recommendations of a professional scientific staff at JDRF based on input from outside scientific reviewers and patient advocates. The following areas are evaluated: (1) The scientific merit of the application. (2) The relationship of the research to the causes, prevention and cure of diabetes and its complications. Also considered are the merits of the institutions and/or sponsors of the applicant, and the applicant's commitment to the continuing diabetes research programs. JDRF staff scrutinize expenditures reported by an institution above a percentage threshold of the approved budget. X X true true X X X X X true false false false false false false false false DR RICHARD A INSEL 486450 0 0 0 50000 0 17677 0 20781 0 574908 0 0 0 EDWARD J SEBALD 232834 0 0 0 0 0 17677 0 20781 0 271292 0 0 0 GERRI BOSTICK 246278 0 0 0 0 0 17677 0 2661 0 266616 0 0 0 JAMES SZMAK 284000 0 0 0 0 0 17677 0 20781 0 322458 0 0 0 DARLENE DEECHER 300000 0 0 0 0 0 17677 0 20781 0 338458 0 0 0 JULIA GREENSTEIN 252938 0 0 0 0 0 17677 0 2677 0 273292 0 0 0 MIKE MALEKOFF 205531 0 0 0 16900 0 15286 0 19049 0 256766 0 0 0 SCOTT MCCORMICK 225000 0 0 0 0 0 0 0 1346 0 226346 0 0 0 HOUSING ALLOWANCE SCHEDULE J PART I, LINE 1A Dr. Insel, highest compensated employee, received a housing allowance that was grossed up as per the terms of his employment agreement. For the 2012 calendar year, the housing allowance provided to Dr. Insel was $50,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B)(iii). SEVERANCE PAYMENTS SCHEDULE J, PART I, LINE 4A MICHAEL MALEKOFF RECEIVED A SEVERANCE PAYMENT OF $16,900 WHICH IS REPORTED ON SCHEDULE J PART II COL.(B)(iii) OTHER REPORTABLE COMPENSATION. PRESIDENT AND CEO FORM 990, PART VII, SECTION A JEFFREY BREWER BECAME PRESIDENT AND CEO OF JDRF ON 6/30/2010. FOR THE CALENDAR YEAR 2012, NO REPORTABLE COMPENSATION WAS PAID. SINCE BECOMING PRESIDENT AND CEO, JEFFREY BREWER HAS NOT TAKEN A SALARY TO DATE. KEY EMPLOYEE- RESEARCH DAVID WHEADON, EVP, THERAPY DEVELOPMENT, RESEARCH WAS HEAD OF JDRF'S RESEARCH DEPARTMENT AND KEY EMPLOYEE FOR THE PERIOD ENDING 6/30/2013. BECAURE HIS HIRE DATE WAS MAY OF 2013 AND HAD NO REPORTABLE WAGES, HE WILL NOT BE LISTED ON FORM 990, PART VII OR SCHEDULE J, AS PART VII AND SCHEDULE J REPORT CALENDAR YEAR 2012 COMPENSATION. RUTH HENDREN DAUGHTER OF MIKE HENDREN 46507 EMPLOYMENT AT JDRF INT. false ELIZABETH KECKLER DAUGHTER OF ELLEN LEAKE 64480 EMPLOYMENT AT JDRF INT. false SCHEDULE L, PART IV, COLUMN C COMPENSATION TOTAL COMPENSATION INCLUDES EMPLOYER PAID BENEFITS X 2 51800 TICKET SALES X 203 2639264 NET PROCEEDS OF SALE X MISC AUCTION ITEMS DONATED- 20,000 DONORS 20000 10925205 THRIFT SHOP false true true CAR PROGRAM LLC LINE 32B THE CAR PROGRAM LLC IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, THE CAR PROGRAM LLC HANDLES ALL IRS 1098-C REPORTING. THE CAR PROGRAM LLC IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/13, THE CAR PROGRAM LLC RAISED $336,159 WITH TOTAL EXPENSES OF $162,381. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY THE CAR PROGRAM ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-13 WAS $173,778. NONCASH CONTRIBUTIONS FORM 990, SCHEDULE M, PAGE 1, TYPES OF PROPERTY THE AMOUNTS LISTED IN PART I LINES 6 & 9 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES AND SECURITIES. LINE 25 COLUMN(b),IS AN ESTIMATE OF MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES. ORGANIZATION'S MISSION PART III, LINE 1 JDRF'S MISSION IS TO FIND A CURE FOR TYPE 1 DIABETES AND ITS COMPLICATIONS THROUGH THE SUPPORT OF RESEARCH. JDRF IS THE LEADING GLOBAL ORGANIZATION FUNDING TYPE 1 DIABETES (T1D) RESEARCH. JDRF'S GOAL IS TO PROGRESSIVELY REMOVE THE IMPACT OF T1D FROM PEOPLE'S LIVES UNTIL WE ACHIEVE OUR VISION OF A WORLD WITHOUT T1D. JDRF COLLABORATES WITH A WIDE SPECTRUM OF PARTNERS AND IS CURRENTLY SPONSORING $530 MILLION IN SCIENTIFIC RESEARCH IN 17 COUNTRIES. STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS: PART III LINE 4A: JDRF'S MISSION IS TO FIND A CURE FOR TYPE 1 DIABETES AND ITS COMPLICATIONS THROUGH THE SUPPORT OF RESEARCH. JDRF IS A GLOBAL ORGANIZATION WITH A STRATEGIC RESEARCH PLAN TO END T1D. OUR PLAN ENSURES THAT THERE WILL BE AN ONGOING STREAM OF LIFE-CHANGING THERAPIES MOVING THROUGH THE RESEARCH PIPELINE FROM DEVELOPMENT TO THE MARKETPLACE THAT LESSEN THE IMPACT OF T1D UNTIL WE ELIMINATE THE DISEASE FROM PEOPLE'S LIVES COMPLETELY. JDRF IS DRIVING RESEARCH ACROSS THE ENTIRE SCIENTIFIC SPECTRUM, FROM DISCOVERY IN THE LABORATORY TO DELIVERY OF NEW TECHNOLOGY AND TREATMENTS TO PATIENTS. IT IS COLLABORATING WITH PUBLIC, PRIVATE, ACADEMIC, AND CORPORATE PARTNERS TO EXPEDITE DELIVERY OF REAL-WORLD SOLUTIONS TO PEOPLE WITH T1D AND THEIR FAMILIES. ADDITIONALLY, JDRF'S INFLUENCE AND LEADERSHIP EXTENDS BEYOND FUNDING RESEARCH. JDRF STRATEGICALLY PARTNERS WITH INDUSTRY, GOVERNMENTS, FOUNDATIONS, ACADEMIA, HEALTHCARE, AND CLINICIANS AS PART OF A GLOBAL EFFORT TO CURE T1D. LINE 4B: IN SUPPORTING ITS RESEARCH GOALS, JDRF ORGANIZES SCIENTIFIC MEETINGS, SYMPOSIA, AND CONFERENCES. IT CONVENES REVIEW BOARDS AND COUNCILS COMPOSED OF SCIENTIFIC EXPERTS, VOLUNTEERS, AND T1D PATIENT REPRESENTATIVES TO REVIEW RESEARCH PROPOSALS AND ENSURE JDRF'S RESEARCH STRATEGY IS ALIGNED WITH THE NEEDS OF THE T1D COMMUNITY AND JDRF PROVIDES SCIENTIFIC UPDATES ON THE RESEARCH IT IS MANAGING. THESE ACTIVITIES ARE CENTRAL TO JDRF'S ROLE IN LEADING AND UNIFYING GLOBAL EFFORTS TO CREATE A WORLD WITHOUT T1D. THIS WORK ALSO ENHANCES JDRF'S ABILITY AND OPPORTUNITY TO FORECAST FUTURE SCIENTIFIC DIRECTIONS, JUDGE THE POTENTIAL EFFICIENCY AND EFFECTIVENESS OF NEW RESEARCH PATHWAYS, AND IDENTIFY GAPS WHERE JDRF CAN FOCUS ITS FUNDING TO MAKE THE MOST IMPACT. JDRF'S LEADERSHIP IN THESE AREAS ENABLES IT TO DRIVE A STRATEGIC PLAN TO BRING ABOUT A CONTINUOUS FLOW OF LIFE-CHANGING THERAPIES AND, ULTIMATELY, A CURE FOR T1D. LINE 4C: Because of its leading role in diabetes research globally, JDRF is in a unique position to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people with the disease and their families, but also those at risk for developing the disease, and the general public. JDRF educates people about the warning signs of diabetes, which can be profoundly helpful in ensuring timely diagnoses and reducing the potential, short-term, catastrophic consequences of type 1 diabetes. JDRF also provides key information about current research directions and progress, and about human clinical trials in which people with the disease can participate (including via JDRF's Clinical Trials Connection service). JDRF chapters around the nation are committed to helping people identify and diagnose diabetes earlier and stay healthier so that they can benefit from a cure and treatments as they are developed. 990 REVIEW PROCESS FORM 990, SECTION B, PART VI, QUESTION 11B THE FIRST STEP IN THE FORM 990 REVIEW PROCESS BEGINS AT THE FINANCE LEVEL WITH THE ORGANIZATION'S TAX MANAGER WORKING WITH OUTSIDE TAX ADVISORS TO PREPARE THE RETURN AND ALL SUPPORTING SCHEDULES. THE RETURN IS PREPARED AND CHECKED FOR ACCURACY. AFTER A DRAFT RETURN IS PREPARED, THE SECOND STEP IN THE REVIEW PROCESS INCLUDES A REVIEW OF THE DRAFT RETURN BY OUR TAX ADVISOR, ATTORNEY, AND CHIEF FINANCIAL OFFICER PRIOR TO AN AUDIT COMMITTEE REVIEW. ANY QUESTIONS AND CHANGES WITH RESPECT TO THE DRAFT FORM 990 ARE ADDRESSED AND MADE. THE THIRD STEP IN THE REVIEW PROCESS IS FOR THE JDRF AUDIT COMMITTEE TO REVIEW THE RETURN WITH OUR OUTSIDE TAX ADVISORS. ONCE THE RETURN IS APPROVED WITH ALL CHANGES AND READY TO FILE, IT IS PASSED ON TO THE BOARD. THE FOURTH AND FINAL STEP IN THE REVIEW PROCESS IS TO PROVIDE A FINAL COPY OF THE RETURN TO EACH VOTING MEMBER OF THE JDRF BOARD OF DIRECTORS BEFORE E-FILING THE FORM 990 WITH THE INTERNAL REVENUE SERVICE. CONFLICT OF INTEREST POLICY FORM 990- PART VI-SECT B, LINE 12C ALL OFFICERS, DIRECTORS, KEY EMPLOYEES, BOARD AND COMMITTEE MEMBERS (BOTH CHAPTERS AND INTERNATIONAL BOARDS) ARE REQUIRED TO SIGN A CONFLICT OF INTEREST POLICY ANNUALLY AND DISCLOSE ANY CONFLICTS. THE OFFICE OF THE PRESIDENT HANDLES THIS PROCESS AND JDRF'S INTERNAL AUDIT DEPARTMENT ANNUALLY AUDITS TO ENSURE COMPLIANCE. IF ANY CONFLICT DOES ARISE, THE BOARD MEMBERS WITH THE CONFLICTS WILL RECUSE THEMSELVES FROM THE MEETING AND/OR VOTE. PROFESSIONAL FUNDRAISING FEES FORM 990 PART I LINE 16a and Part IX, LINE 11e. LW ROBBINS ACTS AS A PFR/FRC FOR THE FUNCTION THEY PERFORM FOR JDRF. THEY ARE A MAILING PROCESSOR WITH VARIOUS FUNCTIONS AS A FUNDRAISING CONSULTANT. THE AMOUNT PAID TO LW ROBBINS WAS $339,000 FOR FUNDRAISING CONSULTATION; THE BALANCE WAS FOR PRODUCTS AND SERVICES INCLUDING ALL DONOR PROSPECT MAIL, BROCHURES, ENVELOPES, AND OTHER SERVICES, AS WELL AS POSTAGE AND HANDLING. PUBLIC DOCUMENTS FORM 990, PAGE 6, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS MAIN WEBSITE: www.jdrf.org. THE PUBLIC MAY ACCESS COPIES OF JDRF'S W-9, ANNUAL REPORT, 990 TAX RETURNS, 501(C)(3) IRS LETTER, & AUDITED FINANCIALS, AT THE FOLLOWING LINK: http://jdrf.org/about-jdrf/financials/ EXECUTIVE COMPENSATION POLICY PART VI, SECTION B, LINES 15a & 15b USING RELIABLE DATA, THE ORGANIZATION OBTAINS OBJECTIVE DATA ON COMPARABLE SALARIES AND BENEFITS FOR SIMILAR ORGANIZATIONS WITH LIKE KIND POSITIONS. THE COMPENSATION AND BENEFITS ARE REVIEWED BY AN AUTHORIZED BODY OR COMMITTEE COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, WHO DETERMINE THAT THE COMPENSATION OF EXECUTIVES AND KEY PERSONNEL IS REASONABLE AND WITHIN ACCEPTABLE LIMITS. THE AUTHORIZED BODY OR COMMITTEE ADEQUATELY DOCUMENTS THE REVIEW OF JDRF EXECUTIVE COMPENSATION AND BENEFITS AND THE BASIS FOR ITS DETERMINATION, CONTEMPORANEOUSLY IN THE MINUTES OF THE COMPENSATION COMMITTEE. DURING THE TAX YEAR ENDED JUNE 30, 2013, JDRF'S COMPENSATION COMMITTEE MET ON DECEMBER 10, 2012 TO REVIEW SALARIES AND BENEFITS UNDER THE PROCEDURES NOTED ABOVE. DIABETES INVESTMENT FUND LLC C/O JDRF - 26 BROADWAY 14TH FLOOR NEW YORK NY 10004 274967989 INVESTMENT DE 100 JDRF CHARITABLE REMAINDER TRUST (5) ANNUITY PA N/A T false false false false false false false false false false false false false false false false false false false false